Patients with metabolic dysfunction-associated steatotic liver disease are at higher risk for cardiovascular and malignancy outcomes than for liver-related risks.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.